Invasc Therapeutics -Developing first-in-class drugs for the cardiometabolic market
Invasc Therapeutics -Developing first-in-class drugs for the cardiometabolic market

News & Updates

Year 2010

Georgia Governor Issues Commendation Recognizing

Date: Jan 19 2010
ATLANTA, Georgia – January 19, 2010 – InVasc Therapeutics, Inc. today announced that in a ceremony held at the Georgia State Capital, Governor Sonny Perdue, presented a Commendation to Dr. Bobby V. Khan, a cardiologist, founder and member of the Board of Directors of InVasc. The Commendation states: “WHEREAS: Dr. Khan is a great asset for our state and has worked tirelessly in his duties as a physician, researcher and educator. The citizens of Georgia are thankful for his ongoing contributions to the health and betterment of our state; now THEREFORE: I, Sonny Perdue, Governor of the state of Georgia, do hereby commend Bobby V. Khan.”  



InVasc Therapeutics to Present at Biotech Showcase 2010 and Announces Domain Name Change

Date: Jan 11 2010
ATLANTA, Georgia – January 11, 2010 – InVasc Therapeutics, Inc. today announced that William D. Johnston, Ph.D., Chief Executive Officer, will present an overview of the Company and its pipeline of products for the treatment and prevention of cardiometabolic diseases at the Biotech Showcase 2010 meeting at the Marine Memorial Club and Hotel in San Francisco on Wednesday January 14, 2010 at 4:40 P.M., Pacific Standard Time.  



News Release Archives

News Release 2010

News Release 2009